Fmoc-O-tert.butyl-L-serine

Fmoc-O-tert.butyl-L-serine is an Fmoc-protected L-serine derivative in which the serine side-chain hydroxyl is protected as a tert-butyl ether, yielding an amino acid building block with two orthogonal protecting groups. The molecule contains a chiral α-carbon (L-configuration), an Fmoc carbamate on the amino functionality, and a tert-butyl-protected alcohol that modulates hydrogen-bonding and controls side-chain reactivity during peptide assembly. The protected hydroxyl and carbamate functionalities provide predictable behavior under standard peptide synthesis conditions, while the Fmoc group enables orthogonal deprotection to regenerate an N-terminal amine for coupling. The resulting amino acid ester-free, solid-state intermediate is commonly handled as a chiral, protected amino acid suitable for downstream peptide construction and side-chain functional transformations.

1. Peptide Synthesis

Fmoc-O-tert.butyl-L-serine is applied in peptide synthesis workflows where orthogonally protected serine residues are required for controlled N- and side-chain chemistry. The Fmoc carbamate supports stepwise solid-phase or solution-phase peptide coupling by masking the α-amino group until deprotection, while the tert-butyl ether protects the serine hydroxyl from acylation and side reactions during amide bond formation. The preserved stereochemistry at the α-carbon maintains stereochemical fidelity of the L-serine unit within growing peptide chains. Side-chain deprotection can later reveal the free hydroxyl for targeted modifications such as phosphorylation mimetics, glycosylation handles, or solubility tuning, enabling peptide analog construction and structure-activity relationship studies. The compound's protected functional group pattern aligns with routine peptide building block preparation and protected amino acid chemistry in synthetic peptide science.

2. Side-Chain Functionalization

Fmoc-O-tert.butyl-L-serine serves as a key intermediate for amino acid derivatization strategies focused on serine side-chain reactivity. The tert-butyl-protected hydroxyl can be selectively unmasked under conditions compatible with the Fmoc strategy, generating a primary alcohol suitable for conversion to activated esters, carbonate derivatives, or linkage points for conjugation chemistry. The Fmoc-protected amine provides a stable handle for sequential transformations without premature N-acylation, supporting controlled introduction of functional groups at defined stages of synthesis. The chiral serine backbone can be incorporated into peptide fragments or peptidomimetic scaffolds, allowing downstream generation of hydroxyl-bearing analogs for biochemical probing. This makes the compound relevant to chemical biology research intermediate preparation and side-chain functionalization routes used in fine chemical synthesis.

3. Bioconjugation Chemistry

Fmoc-O-tert.butyl-L-serine is utilized in bioconjugation and biomolecule modification programs where serine-derived hydroxyl functionality is leveraged for controlled attachment chemistry. The tert-butyl ether protection helps prevent undesired crosslinking or polymerization of the alcohol during intermediate handling, while the Fmoc group can be removed to enable coupling into peptide-based linkers or targeting motifs. The presence of a stereodefined serine unit supports incorporation into linker peptides that maintain conformational characteristics relevant to molecular recognition. After deprotection, the free hydroxyl can participate in derivatization toward conjugation-ready intermediates that connect biomolecules to probes, surfaces, or delivery constructs through oxygen-based linkages. The compound therefore functions as a protected amino acid building block enabling downstream conjugate assembly in chemical manufacturing-oriented linker production and applied biochemical research.

4. Peptidomimetics And SAR Studies

Fmoc-O-tert.butyl-L-serine is suitable for peptidomimetic construction and structure-activity relationship studies that require hydroxyl-bearing stereodefined residues. The protected serine side-chain allows incorporation into constrained analogs while preventing premature functional group interference during scaffold assembly, especially when multiple reactive sites are present. The orthogonal protection pattern supports iterative synthesis of peptide-like structures in which the serine hydroxyl is later revealed for substitution, protection exchange, or conversion into bioisosteres. The L-configuration at the α-carbon provides stereochemical consistency across analog series, supporting SAR workflows that compare hydroxyl chemistry while holding backbone stereochemistry constant. The compound's compatibility with peptide coupling chemistry makes it a practical chiral amino acid intermediate for generating series of functionalized derivatives used in medicinal chemistry and biochemical assay development.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-O-tert.butyl-L-serine is relevant to pharmaceutical manufacturing intermediate preparation where protected amino acid building blocks are used to construct defined peptide components under controlled synthetic sequences. The Fmoc group provides a robust N-protection strategy that can be removed on demand, while the tert-butyl ether protects the serine hydroxyl from side reactions during repeated coupling and purification steps typical of peptide intermediate manufacturing. The chiral, stereochemically specified L-serine unit supports consistent incorporation into manufacturing-grade peptide fragments and process chemistry routes that require predictable functional group behavior. The compound can serve as a starting material for producing serine-containing peptide intermediates that later undergo deprotection and further functionalization to reach target intermediate specifications. This aligns with industrial chemical production needs for orthogonally protected amino acid derivatives used in controlled, stepwise peptide synthesis and fine chemical manufacturing.

1. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

2. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

3. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

4. Cationic cell-penetrating peptides are potent furin inhibitors

5. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients